Choosing a Device for Six Weeks of Home IV Antibiotics in a Patient With Poor Veins
Ms. T is 34 and has a complicated intra-abdominal abscess requiring 6 weeks of IV ertapenem 1 g once daily at home. She teaches middle school, has had four failed peripheral IV attempts in the past month, and describes her veins as 'gone.' She has no history of DVT, lymphedema, mastectomy, or kidney disease. Her home infusion nurse can visit three times weekly, and the pharmacy delivers supplies weekly. She wants 'the smallest, least visible' device, is worried about missing work, and swims laps at the Y three mornings a week. She asks why she cannot simply get a peripheral IV whenever a dose is due.
1. Compare the realistic options for this patient and make a recommendation with your reasoning.
Read the worked answer
Repeated peripheral catheters: a 6-week course of daily dosing means roughly 40 separate punctures in a patient with documented failed access. Peripheral catheters are intended for short courses (generally under about 6 days) of non-irritant therapy. This option fails on reliability and on her own history.
Midline: sits in the upper arm with the tip in the axillary or subclavian region, suitable for non-vesicant therapy with pH 5-9 and osmolality under about 900 mOsm/L. Ertapenem fits. However, typical dwell is on the order of weeks, and 6 weeks of daily infusions sits at or beyond the usual limit, with higher thrombosis risk and no tip in the central circulation.
PICC: tip in the distal superior vena cava or cavoatrial junction, appropriate for weeks to months of daily therapy, usable for blood sampling, and manageable by a home infusion nurse. Risks are CLABSI, thrombosis, and maintenance burden, and she cannot swim with it.
Port: cosmetically the best fit and swimming is permitted once fully healed, but it requires a procedure, weekly needle access for daily infusions, and is disproportionate for a first 6-week course.
Recommendation: PICC, with a plan to convert to a port if therapy extends beyond roughly 3 months or if she needs repeated prolonged courses. It matches duration, drug characteristics, her access history, and her need to work reliably.
2. How would your recommendation change if she had stage 4 chronic kidney disease with a planned arteriovenous fistula, or a prior mastectomy with axillary node dissection?
Read the worked answer
Stage 4 CKD with a planned fistula: this changes the answer substantially. Central catheters, including PICCs, can cause venous stenosis and thrombosis that destroy future access sites. Best practice is to avoid PICC placement and preserve the veins of both arms, notify nephrology before any central device is placed, and document vein preservation. Options then include a midline in a carefully chosen vessel if the therapy fits, a short peripheral course if the duration could be reduced, or a device placed in consultation with the access team. The need for 6 weeks of antibiotics does not automatically override the lifetime need for dialysis access.
Prior mastectomy with axillary node dissection: avoid that arm for PICC or midline placement because of lymphedema risk; place the device in the unaffected arm and teach her not to allow blood pressures, venipuncture, or infusions on the affected side.
General principle: device choice is not only about the drug and duration. It is about the patient's entire venous future - kidney function, lymphatic integrity, handedness, occupation, and what therapy she is likely to need next year.
3. Two weeks later she calls the infusion nurse during her dose with a temperature of 38.6 C and rigors. The exit site looks clean and dry. What is your assessment and immediate plan?
Read the worked answer
Assume a central line-associated bloodstream infection until proven otherwise. A normal-appearing exit site does not exclude CLABSI - the infection is in the lumen or the bloodstream, and the site is often unremarkable. Rigors during an infusion raise concern for a contaminated infusate, so also consider the pharmacy and the batch.
Immediate plan:
- Stop the infusion. Do not flush the line or use it for anything except as directed after cultures.
- Assess for sepsis: full vital signs, mental status, capillary refill, urine output, skin, and any abdominal source.
- Direct her to the emergency department or contact the provider for immediate evaluation - this is not a next-visit problem.
- Blood cultures before antibiotics: at least one set from the catheter and one from a peripheral site, labeled with times, so the lab can compare differential time to positivity.
- Do not administer the next antibiotic dose through the line until cultures are drawn, and clarify with the provider whether the line should be removed - for serious infection, especially with hypotension or a difficult-to-treat organism, removal is often required.
- Notify the provider, pharmacy, and home infusion agency; preserve the current bag and tubing and check the delivery and hang records.
Teach her to call with any fever, chills, or rigors during or after an infusion, and review her dressing and hub care at the next visit.